Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16259522 | 0.84 | KDM4C (0.42) | ALDH1A1PAOXPOLBCACNA1HSMN1; SMN2 | |
| SCHEMBL15001319 | 0.84 | CNR1 (0.44) | ALDH1A1HSD17B10POLBCACNA1HSMN1; SMN2 | |
| SCHEMBL9499386 | 0.84 | CNR1 (0.34) | ALDH1A1CYP2C9HPGDALOX15CYP2C19 | |
| SCHEMBL10297996 | 0.84 | RIPK1 (0.46) | ALDH1A1CYP2C9HPGDALOX15CYP2C19 | |
| SCHEMBL422608 | 0.81 | POLB (0.44) | ALDH1A1CYP2C9HPGDALOX15CYP2C19 | |
| SCHEMBL11957576 | 0.81 | ALDH1A1 (0.37) | ALDH1A1CYP2C9HPGDALOX15CYP2C19 | |
| SCHEMBL15001317 | 0.81 | PTGS1 (0.44) | ALDH1A1PAOXPOLBSMN1; SMN2MEN1 | |
| SCHEMBL15001543 | 0.81 | ECE1 (0.39) | CYP1A2TSHRKMT2ABLMKDM4E | |
| SCHEMBL20221181 | 0.81 | ALDH1A1 (0.35) | ALDH1A1POLBCACNA1HSMN1; SMN2CNR1 | |
| SCHEMBL16259681 | 0.81 | PAOX (0.36) | ALDH1A1PAOXPOLBCACNA1HSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023178299-A1 | PRODRUGS OF GANAXOLONE | MARINUS PHARMACEUTICALS, INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| EP-2496596-B1 | THERAPEUTIC PEPTIDES | LYTIX BIOPHARMA AS (NO) | 2017-01-11 | — | — | EP | disclosed |
| US-8809280-B2 | Therapeutic peptides | LYTIX BIOPHARMA AS (NO) | 2014-08-19 | — | — | US | disclosed |
| US-20130035296-A1 | THERAPEUTIC PEPTIDES | LYTIX BIOPHARMA AS (NO) | 2013-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035296-A1 | THERAPEUTIC PEPTIDES | VIP, LNPEP, ANPEP | ALDH1A1 4783/4885CYP2C9 4869/4885HPGD 3389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.